NTRA PS Ratio
Industry PS Ratio
S&P 500 PS Ratio
17.3
4.2
3.3
NTRA Revenue Forecast
Industry Revenue Forecast
S&P 500 Revenue Forecast
20.9%
8.7%
11.9%
Wall Street X rates NTRA a BUY, and the average consensus rating is a STRONG BUY.
Wall Street X has a price target of $380.09 for NTRA, and the average consensus target is $321.37 .
To buy shares of NTRA, open an account with an online brokerage, deposit money from your bank, search for “NTRA”, choose the number of shares or dollar amount, and place a trade.
Natera is a diagnostic company that makes money by developing and selling genetic testing solutions, particularly in prenatal and oncology health. It generates revenue by performing these specialized diagnostic tests for healthcare providers.
This Natera, Inc. (NASDAQ: NTRA) page was last updated on September 4, 2026 by wallstreetx.com.